» Articles » PMID: 12792509

A New Epitope-based HLA-DPB Matching Approach for Cadaver Kidney Retransplants

Overview
Journal Transplantation
Specialty General Surgery
Date 2003 Jun 7
PMID 12792509
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several years ago a significant impact of matching for HLA-DPB1 alleles on the survival of cadaver kidney retransplants was shown. Here we report the results of a new approach, based on matching for HLA-DPB1 epitopes.

Methods: The analysis is based on 1,478 patients who received a cadaver kidney retransplant between 1988 and 1998. DNA methodology (polymerase chain reaction, sequence-specific oligonucleotides) was used to perform HLA-DPB1 typing. Epitope matching was facilitated with the aid of sequence databases and computer calculations.

Results: Matching for the HLA-DP epitopes A, B, E, and F, corresponding to the homonymous hypervariable regions of the second exon of the DPB1 gene, seems to have a greater influence on graft survival than matching for the epitopes C and D. Within a group of 529 retransplants with exactly one allelic HLA-DPB1 mismatch, a significantly better graft outcome was observed when less than two epitope mismatches were found, compared with the group with more than three epitope mismatches (at 2 years: 77.8% vs. 65.8%, P=0.0112). Importantly, patients with two DPB1 allele mismatches who had less than or equal to two epitope mismatches exhibited a significantly better graft outcome than recipients who had one HLA-DPB1 allelic mismatch but more than three epitope mismatches (at 2 years: 77.1% vs. 65.8%, P=0.0488).

Conclusions: The findings indicate that the impact of HLA-DPB1 matching on the outcome of kidney retransplants is a result of the predominant immunogenicity of certain epitopes of the HLA-DP molecule. Matching for immunogenic HLA-DPB1 epitopes seems to be functionally more relevant than classical matching at the allelic level.

Citing Articles

Isolated Pre-existing HLA-DP Donor-Specific Antibodies are Associated With Poorer Outcomes in Renal Transplantation.

Seitz A, Mounsey K, Hughes P, Cullen K, Welberry Smith M, Daga S Kidney Int Rep. 2022; 7(10):2251-2263.

PMID: 36217531 PMC: 9546735. DOI: 10.1016/j.ekir.2022.07.014.


Resolving MiSeq-Generated Ambiguities in HLA-DPB1 Typing by Using the Oxford Nanopore Technology.

Duke J, Mosbruger T, Ferriola D, Chitnis N, Hu T, Tairis N J Mol Diagn. 2019; 21(5):852-861.

PMID: 31173929 PMC: 6734860. DOI: 10.1016/j.jmoldx.2019.04.009.


The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.

Filippone E, Farber J J Immunol Res. 2017; 2016:5197396.

PMID: 28070526 PMC: 5192322. DOI: 10.1155/2016/5197396.


Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report.

Song S, Park B, Lee J, Kim M, Kim Y, Kim H Medicine (Baltimore). 2016; 95(32):e4521.

PMID: 27512872 PMC: 4985327. DOI: 10.1097/MD.0000000000004521.


Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen.

Hickey M, Valenzuela N, Reed E Front Immunol. 2016; 7:30.

PMID: 26870045 PMC: 4740371. DOI: 10.3389/fimmu.2016.00030.